ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Australia grants Patent to Krystal Biotech
October 08, 2019This patent covers pharmaceutical compositions comprising KB103, as well as to medical uses thereof, e.g., in the treatment of wounds, disorders, or diseases of the skin, particularly those found in epidermolysis bullosa patients. -
Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (“GEM-2 study”) of KB103 and Receives Regenerative Medicine Advanced Therapy (“RMAT”) Designation from FDA for KB103
June 28, 2019Krystal Biotech, Inc. (Nasdaq: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from rare dermatological diseases ... -
Krystal Biotech Completes Construction of New GMP Facility
January 16, 2019Krystal Biotech announced construction of Ancoris, a new state-of-the-art Good Manufacturing Practice (GMP) facility, is complete...
Pharma Sources Insight January 2025
